KDM3A Antikörper (AA 1-300)
-
- Target Alle KDM3A Antikörper anzeigen
- KDM3A (Lysine (K)-Specific Demethylase 3A (KDM3A))
-
Bindungsspezifität
- AA 1-300
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser KDM3A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Sequenz
- MVLTLGESWP VLVGRRFLSL SAADGSDGSH DSWDVERVAE WPWLSGTIRA VSHTDVTKKD LKVCVEFDGE SWRKRRWIEV YSLLRRAFLV EHNLVLAERK SPEISERIVQ WPAITYKPLL DKAGLGSITS VRFLGDQQRV FLSKDLLKPI QDVNSLRLSL TDNQIVSKEF QALIVKHLDE SHLLKGDKNL VGSEVKIYSL DPSTQWFSAT VINGNPASKT LQVNCEEIPA LKIVDPSLIH VEVVHDNLVT CGNSARIGAV KRKSSENNGT LVSKQAKSCS EASPSMCPVQ SVPTTVFKEI
- Kreuzreaktivität
- Human, Maus, Ratte
- Produktmerkmale
- Polyclonal Antibodies
- Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-300 of human KDM3A (NP_060903.2).
- Isotyp
- IgG
- Top Product
- Discover our top product KDM3A Primärantikörper
-
-
- Applikationshinweise
- WB,1:500 - 1:2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model." in: Clinical epigenetics, Vol. 8, pp. 34, (2016) (PubMed).
: "
-
Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model." in: Clinical epigenetics, Vol. 8, pp. 34, (2016) (PubMed).
-
- Target
- KDM3A (Lysine (K)-Specific Demethylase 3A (KDM3A))
- Andere Bezeichnung
- KDM3A (KDM3A Produkte)
- Synonyme
- JHDM2A antikoerper, JHMD2A antikoerper, JMJD1 antikoerper, JMJD1A antikoerper, TSGA antikoerper, tsga antikoerper, jmjd1 antikoerper, jhdm2a antikoerper, jhmd2a antikoerper, jmjd1a antikoerper, 1700105C21Rik antikoerper, C230043E16Rik antikoerper, JHDM2a antikoerper, Jmjd1 antikoerper, Jmjd1a antikoerper, KDM2A antikoerper, TGSA antikoerper, Tsga antikoerper, mKIAA0742 antikoerper, KDM3A antikoerper, kdm3a antikoerper, lysine demethylase 3A antikoerper, lysine (K)-specific demethylase 3A antikoerper, lysine-specific demethylase 3A antikoerper, lysine (K)-specific demethylase 3A S homeolog antikoerper, KDM3A antikoerper, kdm3a antikoerper, Kdm3a antikoerper, LOC100453519 antikoerper, kdm3a.S antikoerper
- Hintergrund
- This gene encodes a zinc finger protein that contains a jumonji domain and may play a role in hormone-dependent transcriptional activation. Alternative splicing results in multiple transcript variants.,KDM3A,JHDM2A,JHMD2A,JMJD1,JMJD1A,TSGA,Epigenetics & Nuclear Signaling,Chromatin Modifying Enzymes,Demethylation,KDM3A
- Molekulargewicht
- 147 kDa
- Gen-ID
- 55818
- UniProt
- Q9Y4C1
- Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Nuclear Hormone Receptor Binding, Warburg Effekt
-